Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children

Abstract

These data suggest that systemic corticosteroids and methotrexate in combination are beneficial and well tolerated in the treatment of children with LS. Because of the risk of relapse after discontinuing therapy, long-term monitoring is mandatory.